What changed
From · resolution motion · 12 Sept 2024 B-10-2024-0021 on the draft Commission regulation amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for cyproconazole and spirodiclofen in or on certain products
To · Adopted text · 18 Sept 2024 TA-10-2024-0007 Objection to an implementing act: Maximum residue levels for cyproconazole
The two versions differ only in presentation — cover page, numbering or the parts a report carries that the adopted text does not.
+4 added · −2 removed · 0 modified paragraphs (every paragraph that differs, packaging included)
B100021/2024
P10_TA(2024)0007
European Parliament resolution on the draft Commission regulation amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for cyproconazole and spirodiclofen in or on certain products (D091952/05 – 2024/2759(RPS))
Objection to an implementing act: Maximum residue levels for cyproconazole
PE763.091
European Parliament resolution of 18 September 2024 on the draft Commission regulation amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for cyproconazole and spirodiclofen in or on certain products (D091952/05 – 2024/2759(RPS))
The European Parliament,